(HealthDay)—Salpingectomy alone may be a risk management option for women at hereditary risk of ovarian cancer, according to a review published in the May issue of Cancer Prevention Research.
Apr 22, 2015
0
3
A study from The Wistar Institute demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of stem-like chemoresistant cells following cisplatin treatment. Researchers showed that a combination ...
Dec 20, 2019
0
4
A recent study used a big data multi-omics analysis to examine changes in gene expression as cells from human fallopian tubes become cancerous.
Jan 12, 2024
0
2
Scientists at A*STAR's Institute of Medical Biology (IMB) and the Bioinformatics Institute (BII) have found new clues to early detection and personalised treatment of ovarian cancer, currently one of the most difficult cancers ...
Aug 8, 2014
0
0
A new imaging test may provide the ability to identify ovarian cancer patients who are candidates for an emerging treatment that targets a key enzyme cancer cells need to survive. Currently, epithelial ovarian cancer patients ...
Apr 3, 2017
0
24
Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University in St. Louis has found an innovative way to use sound ...
Nov 14, 2018
0
6
(HealthDay)—Guidelines have been developed for neoadjuvant chemotherapy use for newly diagnosed, advanced ovarian cancer. The clinical practice guideline was published online Aug. 8 in the Journal of Clinical Oncology.
Aug 9, 2016
0
15
(Medical Xpress) -- Could ovulation be the link to ovarian cancer? Joanna Burdette of the University of Illinois at Chicago College of Pharmacy thinks it might be, and she's working to find out.
Jul 24, 2012
0
0
Increased fluidity in cell membranes could have a major impact on an ovarian cancer cell's sensitivity to treatment using the anti-rheumatic drug auranofin, research led by Plymouth University suggests.
Sep 28, 2016
0
2
Women with the commonest type of ovarian cancer can safely take hormone replacement therapy (HRT), and it could have a beneficial effect on their survival, a long-term clinical trial reports.
Sep 28, 2015
0
96
